CD4 and COVID-19: For example, CD4+ T cells from patients with severe COVID-19 produce elevated levels of TNF-α, associated with impaired proliferative capacity of SARS-CoV-2-specific CD4+ T cells and increasing their susceptibility to activation-induced cell death.